Metabolic syndrome is associated with reduced flow mediated dilation independent of obesity status

in European Journal of Endocrinology
View More View Less
  • 1 Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK
  • 2 Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK
  • 3 Obesity and Endocrinology Research Group, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
  • 4 Department of Sport and Exercise Sciences, Manchester Metropolitan University, Manchester, UK
  • 5 Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK
  • 6 Institute of Psychology Health and Society, University of Liverpool, Liverpool, UK
  • 7 Liverpool Magnetic Resonance Imaging Centre (LiMRIC), University of Liverpool, Liverpool, UK

Correspondence should be addressed to V S Sprung; Email: V.S.Sprung@ljmu.ac.uk

*(V S Sprung and K A Bowden Davies contributed equally to this work)

Restricted access

Background

Data suggest that metabolic health status, incorporating components of metabolic syndrome (MetS), predicts cardiovascular disease (CVD) risk better than BMI. This study explored the association of MetS and obesity with endothelial function, a prognostic risk factor for incident CVD.

Methods

Forty-four participants were phenotyped according to BMI as non-obese vs obese (<30 or >30 kg/m2) and according to the International Diabetes Federation criteria of MetS: ≤2 criteria MetS (MetS−) vs ≥3 criteria MetS (MetS+); (1.)non-obese MetS− vs (2.) non-obese MetS+ and (3.) obese MetS vs (4.) obese MetS+. Flow-mediated dilation (FMD), body composition including liver fat (MRI and spectroscopy), dietary intake, intensities of habitual physical activity and cardio-respiratory fitness were determined. Variables were analysed using a one-factor between-groups ANOVA and linear regression; mean (95% CI) are presented.

Results

Individuals with MetS+ displayed lower FMD than those with MetS−. For non-obese individuals mean difference between MetS+ and MetS− was 4.1% ((1.0, 7.3); P = 0.004) and obese individuals had a mean difference between MetS+ and MetS− of 6.2% ((3.1, 9.2); P < 0.001). Although there was no association between BMI and FMD (P = 0.27), an increased number of MetS components was associated with a lower FMD (P = 0.005), and after adjustment for age and sex, 19.7% of the variance of FMD was explained by MetS, whereas only 1.1% was explained by BMI.

Conclusions

In this study cohort, components of MetS, rather than obesity per se, contribute to reduced FMD, which suggests a reduced bioavailability of nitric oxide and thus increased risk of CVD.

 

     European Society of Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 1178 1178 105
Full Text Views 57 57 5
PDF Downloads 30 30 4
  • 1

    Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H & Freeman LB Body-mass index and mortality among 1.46 million white adults. New England Journal of Medicine 2010 363 22112219. (https://doi.org/10.1056/NEJMoa1000367)

    • Search Google Scholar
    • Export Citation
  • 2

    Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013 309 7182. (https://doi.org/10.1001/jama.2012.113905)

    • Search Google Scholar
    • Export Citation
  • 3

    Troiano RP, Frongillo EA Jr, Sobal J, Levitsky DA. The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. International Journal of Obesity and Related Metabolic Disorders 1996 20 6375.

    • Search Google Scholar
    • Export Citation
  • 4

    Carnethon MR, Rasmussen-Torvik LJ, Palaniappan L. The obesity paradox in diabetes. Current Cardiology Reports 2014 16 446. (https://doi.org/10.1007/s11886-013-0446-3)

    • Search Google Scholar
    • Export Citation
  • 5

    Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. Journal of the American College of Cardiology 2009 53 19251932. (https://doi.org/10.1016/j.jacc.2008.12.068)

    • Search Google Scholar
    • Export Citation
  • 6

    Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM & Smith SC Jr Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009 120 16401645. (https://doi.org/10.1161/CIRCULATIONAHA.109.192644)

    • Search Google Scholar
    • Export Citation
  • 7

    Caleyachetty R, Thomas GN, Toulis KA, Mohammed N, Gokhale KM, Balachandran K, Nirantharakumar K. Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. Journal of the American College of Cardiology 2017 70 14291437. (https://doi.org/10.1016/j.jacc.2017.07.763)

    • Search Google Scholar
    • Export Citation
  • 8

    Phillips CM. Metabolically healthy obesity across the life course: epidemiology, determinants, and implications. Annals of the New York Academy of Sciences 2017 1391 85100. (https://doi.org/10.1111/nyas.13230)

    • Search Google Scholar
    • Export Citation
  • 9

    Stefan N, Schick F, Häring HU. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metabolism 2017 26 292300. (https://doi.org/10.1016/j.cmet.2017.07.008)

    • Search Google Scholar
    • Export Citation
  • 10

    Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses’ Health Study): 30 year follow-up from a prospective cohort study. Lancet: Diabetes and Endocrinology 2018 6 714724. (https://doi.org/10.1016/S2213-8587(18)30137-2)

    • Search Google Scholar
    • Export Citation
  • 11

    Khan SS, Ning H, Wilkins JT, Allen N, Carnethon M, Berry JD, Sweis RN, Lloyd-Jones DM. Association of body mass index with lifetime risk of cardiovascular disease and compression of Morbidity Association. JAMA Cardiology 2018 3 280287. (https://doi.org/10.1001/jamacardio.2018.0022)

    • Search Google Scholar
    • Export Citation
  • 12

    Morkedal B, Vatten LJ, Romundstad PR, Laugsand LE, Janszky I. Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trondelag Health Study), Norway. Journal of the American College of Cardiology 2014 63 10711078. (https://doi.org/10.1016/j.jacc.2013.11.035)

    • Search Google Scholar
    • Export Citation
  • 13

    Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. Journal of Clinical Endocrinology and Metabolism 2012 97 24822488. (https://doi.org/10.1210/jc.2011-3475)

    • Search Google Scholar
    • Export Citation
  • 14

    Mongraw-Chaffin M, Foster MC, Anderson CAM, Burke GL, Haq N, Kalyani RR, Ouyang P, Sibley CT, Tracy R & Woodward M Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. Journal of the American College of Cardiology 2018 71 18571865. (https://doi.org/10.1016/j.jacc.2018.02.055)

    • Search Google Scholar
    • Export Citation
  • 15

    Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980 288 373376. (https://doi.org/10.1038/288373a0)

    • Search Google Scholar
    • Export Citation
  • 16

    Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G. Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter? Hypertension 2011 57 363369. (https://doi.org/10.1161/HYPERTENSIONAHA.110.167015)

    • Search Google Scholar
    • Export Citation
  • 17

    Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, Hamburg NM, Lüscher TF, Shechter M & Taddei S The assessment of endothelial function: from research into clinical practice. Circulation 2012 126 753767. (https://doi.org/10.1161/CIRCULATIONAHA.112.093245)

    • Search Google Scholar
    • Export Citation
  • 18

    Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. Journal of the American College of Cardiology 2003 42 11491160. (https://doi.org/10.1016/s0735-1097(03)00994-x)

    • Search Google Scholar
    • Export Citation
  • 19

    De Boer MP, Meijer RI, Wijnstok NJ, Jonk AM, Houben AJ, Stehouwer CD, Smulders YM, Eringa EC, Serné EH. Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Microcirculation 2012 19 518. (https://doi.org/10.1111/j.1549-8719.2011.00130.x)

    • Search Google Scholar
    • Export Citation
  • 20

    Jonk AM, Houben AJ, de Jongh RT, Serne EH, Schaper NC, Stehouwer CD. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology 2007 22 252260. (https://doi.org/10.1152/physiol.00012.2007)

    • Search Google Scholar
    • Export Citation
  • 21

    Inaba Y, Chen JA, Bergmann SR. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. International Journal of Cardiovascular Imaging 2010 26 631640. (https://doi.org/10.1007/s10554-010-9616-1)

    • Search Google Scholar
    • Export Citation
  • 22

    Sprung VS, Jones H, Pugh CJ, Aziz NF, Daousi C, Kemp GJ, Green DJ, Cable NT, Cuthbertson DJ. Endothelial dysfunction in hyperandrogenic polycystic ovary syndrome is not explained by either obesity or ectopic fat deposition. Clinical Science 2014 126 6774. (https://doi.org/10.1042/CS20130186)

    • Search Google Scholar
    • Export Citation
  • 23

    Cuthbertson DJ, Shojaee-Moradie F, Sprung VS, Jones H, Pugh CJ, Richardson P, Kemp GJ, Barrett M, Jackson NC & Thomas EL Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homeostasis in obese patients with non-alcoholic fatty liver disease. Clinical Science 2016 130 93104. (https://doi.org/10.1042/CS20150447)

    • Search Google Scholar
    • Export Citation
  • 24

    Cuthbertson DJ, Irwin A, Gardner CJ, Daousi C, Purewal T, Furlong N, Goenka N, Thomas EL, Adams VL & Pushpakom SP Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists. PLoS ONE 2012 7 e50117. (https://doi.org/10.1371/journal.pone.0050117)

    • Search Google Scholar
    • Export Citation
  • 25

    Todd CS, Jones HE, Garber TC, Afnan-Holmes H, Woolgar H, Bekker LG, Myer L. Awareness and interest in intrauterine contraceptive device use among HIV-positive women in Cape Town, South Africa. Infectious Diseases in Obstetrics and Gynecology 2012 2012 956145. (https://doi.org/10.1155/2012/956145)

    • Search Google Scholar
    • Export Citation
  • 26

    Johannsen DL, Calabro MA, Stewart J, Franke W, Rood JC, Welk GJ. Accuracy of armband monitors for measuring daily energy expenditure in healthy adults. Medicine and Science in Sports and Exercise 2010 42 21342140. (https://doi.org/10.1249/MSS.0b013e3181e0b3ff)

    • Search Google Scholar
    • Export Citation
  • 27

    Scheers T, Philippaerts R, Lefevre J. Variability in physical activity patterns as measured by the SenseWear Armband: how many days are needed? European Journal of Applied Physiology 2012 112 16531662. (https://doi.org/10.1007/s00421-011-2131-9)

    • Search Google Scholar
    • Export Citation
  • 28

    Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behavior Research Methods 2009 41 11491160. (https://doi.org/10.3758/BRM.41.4.1149)

    • Search Google Scholar
    • Export Citation
  • 29

    Atkinson G, Batterham AM, Thijssen DH, Green DJ. A new approach to improve the specificity of flow-mediated dilation for indicating endothelial function in cardiovascular research. Journal of Hypertension 2013 31 287291. (https://doi.org/10.1097/HJH.0b013e32835b8164)

    • Search Google Scholar
    • Export Citation
  • 30

    Atkinson G, Batterham AM. Allometric scaling of diameter change in the original flow-mediated dilation protocol. Atherosclerosis 2013 226 425427. (https://doi.org/10.1016/j.atherosclerosis.2012.11.027)

    • Search Google Scholar
    • Export Citation
  • 31

    Khan UI, Wang D, Thurston RC, Sowers M, Sutton-Tyrrell K, Matthews KA, Barinas-Mitchell E, Wildman RP. Burden of subclinical cardiovascular disease in ‘metabolically benign’ and ‘at-risk’ overweight and obese women: the Study of Women’s Health Across the Nation (SWAN). Atherosclerosis 2011 217 179186. (https://doi.org/10.1016/j.atherosclerosis.2011.01.007)

    • Search Google Scholar
    • Export Citation
  • 32

    Brant LC, Wang N, Ojeda FM, LaValley M, Barreto SM, Benjamin EJ, Mitchell GF, Vasan RS, Palmisano JN & Münzel T Relations of metabolically healthy and unhealthy obesity to digital vascular function in three community-based cohorts: a meta-analysis. Journal of the American Heart Association 2017 6 e004199. (https://doi.org/10.1161/JAHA.116.004199)

    • Search Google Scholar
    • Export Citation
  • 33

    Dobson R, Burgess MI, Sprung VS, Irwin A, Hamer M, Jones J, Daousi C, Adams V, Kemp GJ & Shojaee-Moradie F Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. International Journal of Obesity 2016 40 153161. (https://doi.org/10.1038/ijo.2015.151)

    • Search Google Scholar
    • Export Citation
  • 34

    Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C. The implication of obesity and central fat on markers of chronic inflammation: the Attica study. Atherosclerosis 2005 183 308315. (https://doi.org/10.1016/j.atherosclerosis.2005.03.010)

    • Search Google Scholar
    • Export Citation
  • 35

    Phillips CM, Dillon C, Harrington JM, McCarthy VJ, Kearney PM, Fitzgerald AP, Perry IJ. Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS ONE 2013 8 e76188. (https://doi.org/10.1371/journal.pone.0076188)

    • Search Google Scholar
    • Export Citation
  • 36

    Myers J, McAuley P, Lavie CJ, Despres JP, Arena R, Kokkinos P. Physical activity and cardiorespiratory fitness as major markers of cardiovascular risk: their independent and interwoven importance to health status. Progress in Cardiovascular Diseases 2015 57 306314. (https://doi.org/10.1016/j.pcad.2014.09.011)

    • Search Google Scholar
    • Export Citation
  • 37

    Ortega FB, Cadenas-Sanchez C, Sui X, Blair SN, Lavie CJ. Role of fitness in the metabolically healthy but obese phenotype: a review and update. Progress in Cardiovascular Diseases 2015 58 7686. (https://doi.org/10.1016/j.pcad.2015.05.001)

    • Search Google Scholar
    • Export Citation
  • 38

    Barry VW, Baruth M, Beets MW, Durstine JL, Liu J, Blair SN. Fitness vs. fatness on all-cause mortality: a meta-analysis. Progress in Cardiovascular Diseases 2014 56 382390. (https://doi.org/10.1016/j.pcad.2013.09.002)

    • Search Google Scholar
    • Export Citation
  • 39

    Muñoz-Garach A, Cornejo-Pareja I, Tinahones FJ. Does metabolically healthy obesity exist? Nutrients 2016 8 320. (https://doi.org/10.3390/nu8060320)

    • Search Google Scholar
    • Export Citation
  • 40

    Kouvari M, Panagiotakos DB, Yannakoulia M, Georgousopoulou E, Critselis E, Chrysohoou C, Tousoulis D, Pitsavos C. Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: the Attica cohort study. Metabolism 2019 93 1824. (https://doi.org/10.1016/j.metabol.2019.01.003)

    • Search Google Scholar
    • Export Citation
  • 41

    Phillips CM. Metabolically healthy obesity: definitions, determinants and clinical implications. Reviews in Endocrine and Metabolic Disorders 2013 14 219227. (https://doi.org/10.1007/s11154-013-9252-x)

    • Search Google Scholar
    • Export Citation
  • 42

    Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 2009 120 502509. (https://doi.org/10.1161/CIRCULATIONAHA.109.864801)

    • Search Google Scholar
    • Export Citation